Virtual Clinical Trials Market, Global Outlook and Forecast
2022-2028 Market
Virtual Clinical Trials Market, Global Outlook and Forecast 2022-2028 Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Virtual Clinical Trials Market, Global Outlook and Forecast 2022-2028 Market Size and Growth
The global virtual clinical trials market is projected to experience significant growth from 2022 to 2028 due to the increasing adoption of virtual technologies in clinical research. The market size is expected to reach a value of USD 7.8 billion by 2028, driven by the demand for more efficient and patient-centric trial processes.
Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ ICON Plc
◍ LEO Innovation Lab
◍ Science 37
◍ PRA Health Sciences
◍ Clinical Ink
◍ Parexel
◍ Medable
◍ Oracle
◍ CRF Health
◍ Medidata
◍ Covance
◍ IQVIA
The competitive landscape of the Virtual Clinical Trials Market includes key players such as ICON Plc, LEO Innovation Lab, Science 37, PRA Health Sciences, Clinical Ink, Parexel, Medable, Oracle, CRF Health, Medidata, Covance, and IQVIA. These companies leverage virtual clinical trials to streamline processes, improve patient recruitment, and enhance data collection, ultimately contributing to the growth of the market.
- ICON PLC: $2.8 billion
- PRA Health Sciences: $3.2 billion
- Parexel: $1.2 billion Request Sample Report
Market Segmentation
By Application
Oncology
Cardiovascular Disease
Others
Request Sample Report
By Product
Interventional Trials
Observational Trials
Expanded Access Trials
Market Growth
Request Sample Report
$ X Billion USD
